New York, September 3, 2013 — NeoStem, Inc. (Nasdaq: NBS) (“NeoStem” or the “Company”), a leader in the emerging cellular therapy market, announced today that the Company and its subsidiary, Progenitor Cell Therapy (“PCT”), will present at multiple upcoming conferences in September.
European Society of Cardiology Congress: Acute Cardiac Care 2013
- Date and Time: Tuesday, September 3, 3:30 PM CEST
- Venue: Congress Centre, Amsterdam, The Netherlands
- Session: Infarction acute phase STEMI (Moderated posters)
- Speaker: Jonathan Sackner-Bernstein, MD, FACC, Vice President, Clinical Development and Regulatory Affairs
Rodman & Renshaw 15th Annual Healthcare Conference
- Date and Time: Monday, September 9, 10:50 AM EDT
- Venue: Millennium Broadway Hotel, New York, New York
- Session: Company presentation
- Speaker: Robin L. Smith, MD, MBA, Chairman and CEO
International Society for Cellular Therapy (ISCT) North American Regional Meeting 2013
- Date and Time: Tuesday, September 10, 10:30 AM EDT
- Venue: Hyatt at Penn’s Landing, Philadelphia, Pennsylvania
- Session: Commercialization Case Study: Cell Therapy from Concept to Market
- Speaker: Robert A. Preti, Ph.D., Chief Scientific Officer, NeoStem, and President, Progenitor Cell Therapy (PCT)
Stifel Annual Healthcare Conference 2013
- Date and Time: Wednesday, September 11, 2:40 PM EDT
- Venue: Four Seasons Hotel, Boston, Massachusetts
- Session: Company presentation
- Speaker: Robin L. Smith, MD, MBA, Chairman and CEO
Heart Failure Society of America 17th Annual Scientific Meeting
- Date and Time: Monday, September 23, 4:00 PM EDT
- Venue: The Peabody Orlando Hotel, Orlando, Florida
- Session: Can Cell Therapy Put Systolic Heart Failure on the Endangered Species List?
- Speaker: Douglas W. Losordo, MD, FACC, FAHA, Chief Medical Officer
Aegis Capital Corp. 2013 Healthcare Conference
- Date and Time: Thursday, September 26, 9:00 AM PDT
- Venue: The Encore at Wynn, Las Vegas, Nevada
- Session: Company Presentation
- Speaker: Robin L. Smith, MD, MBA, Chairman and CEO
BioCentury Newsmakers in the Biotech Industry
- Date and Time: Friday, September 27, 10:00 AM EDT
- Venue: The Millennium Broadway Hotel & Conference Center, New York, New York
- Session: Company Presentation
- Speaker: Robin L. Smith, MD, MBA, Chairman and CEO
The Symposium on Advanced Wound Care
- Date and Time: Saturday, September 28, 4:10 PM PDT
- Venue: Bally’s Las Vegas, Las Vegas, Nevada
- Session: Cell Therapy for Critical Limb Ischemia
- Speaker: Douglas W. Losordo, MD, FACC, FAHA, Chief Medical Officer
Stem Cells & Regenerative Medicine Congress
- Date and Time: Monday, September 30, 1:50 PM EDT
- Venue: The Hyatt Regency, Cambridge, Massachusetts
- Session: Capital formation strategies for stem cell and regenerative medicine companies
- Session Chair: Robin L. Smith, MD, MBA, Chairman and CEO
About NeoStem
NeoStem, Inc. is a leader in the emerging cellular therapy industry. Our business model includes the development of novel proprietary cell therapy products as well as operating a contract development and manufacturing organization providing services to others in the regenerative medicine industry. The combination of a therapeutic development business and revenue-generating service provider business provides the Company with capabilities for cost effective in-house product development and immediate revenue and cash flow generation.
Read Next
